Literature DB >> 23863712

CHIP protects against cardiac pressure overload through regulation of AMPK.

Jonathan C Schisler1, Carrie E Rubel, Chunlian Zhang, Pamela Lockyer, Douglas M Cyr, Cam Patterson.   

Abstract

Protein quality control and metabolic homeostasis are integral to maintaining cardiac function during stress; however, little is known about if or how these systems interact. Here we demonstrate that C terminus of HSC70-interacting protein (CHIP), a regulator of protein quality control, influences the metabolic response to pressure overload by direct regulation of the catalytic α subunit of AMPK. Induction of cardiac pressure overload in Chip-/- mice resulted in robust hypertrophy and decreased cardiac function and energy generation stemming from a failure to activate AMPK. Mechanistically, CHIP promoted LKB1-mediated phosphorylation of AMPK, increased the specific activity of AMPK, and was necessary and sufficient for stress-dependent activation of AMPK. CHIP-dependent effects on AMPK activity were accompanied by conformational changes specific to the α subunit, both in vitro and in vivo, identifying AMPK as the first physiological substrate for CHIP chaperone activity and establishing a link between cardiac proteolytic and metabolic pathways.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23863712      PMCID: PMC3726173          DOI: 10.1172/JCI69080

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation.

Authors:  J Jiang; C A Ballinger; Y Wu; Q Dai; D M Cyr; J Höhfeld; C Patterson
Journal:  J Biol Chem       Date:  2001-09-13       Impact factor: 5.157

2.  A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle.

Authors:  J Mu; J T Brozinick; O Valladares; M Bucan; M J Birnbaum
Journal:  Mol Cell       Date:  2001-05       Impact factor: 17.970

Review 3.  CHIP: a link between the chaperone and proteasome systems.

Authors:  Holly McDonough; Cam Patterson
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

4.  The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation.

Authors:  G C Meacham; C Patterson; W Zhang; J M Younger; D M Cyr
Journal:  Nat Cell Biol       Date:  2001-01       Impact factor: 28.824

5.  The regulation of AMP-activated protein kinase by H(2)O(2).

Authors:  S L Choi; S J Kim; K T Lee; J Kim; J Mu; M J Birnbaum; S Soo Kim; J Ha
Journal:  Biochem Biophys Res Commun       Date:  2001-09-14       Impact factor: 3.575

6.  Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy.

Authors:  R Tian; N Musi; J D'Agostino; M F Hirshman; L J Goodyear
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

Review 7.  Heart failure: a hemodynamic disorder complicated by maladaptive proliferative responses.

Authors:  A M Katz
Journal:  J Cell Mol Med       Date:  2003 Jan-Mar       Impact factor: 5.310

8.  CHIP activates HSF1 and confers protection against apoptosis and cellular stress.

Authors:  Qian Dai; Chunlian Zhang; Yaxu Wu; Holly McDonough; Ryan A Whaley; Virginia Godfrey; Hui-Hua Li; Nageswara Madamanchi; Wanping Xu; Len Neckers; Douglas Cyr; Cam Patterson
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

9.  Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1.

Authors:  Kei Sakamoto; Elham Zarrinpashneh; Grant R Budas; Anne-Catherine Pouleur; Anindya Dutta; Alan R Prescott; Jean-Louis Vanoverschelde; Alan Ashworth; Aleksandar Jovanović; Dario R Alessi; Luc Bertrand
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-12-06       Impact factor: 4.310

Review 10.  Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations.

Authors:  Rajesh Babu Sekar; Ammasi Periasamy
Journal:  J Cell Biol       Date:  2003-03-03       Impact factor: 10.539

View more
  33 in total

1.  CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3.

Authors:  Jinho Seo; Eun-Woo Lee; Hyerim Sung; Daehyeon Seong; Yves Dondelinger; Jihye Shin; Manhyung Jeong; Hae-Kyung Lee; Jung-Hoon Kim; Su Yeon Han; Cheolju Lee; Je Kyung Seong; Peter Vandenabeele; Jaewhan Song
Journal:  Nat Cell Biol       Date:  2016-02-22       Impact factor: 28.824

Review 2.  Proteotoxicity and cardiac dysfunction.

Authors:  Patrick M McLendon; Jeffrey Robbins
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

3.  Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP.

Authors:  Chang-He Shi; Jonathan C Schisler; Carrie E Rubel; Song Tan; Bo Song; Holly McDonough; Lei Xu; Andrea L Portbury; Cheng-Yuan Mao; Cadence True; Rui-Hao Wang; Qing-Zhi Wang; Shi-Lei Sun; Stephanie B Seminara; Cam Patterson; Yu-Ming Xu
Journal:  Hum Mol Genet       Date:  2013-10-09       Impact factor: 6.150

Review 4.  Minireview: hey U(PS): metabolic and proteolytic homeostasis linked via AMPK and the ubiquitin proteasome system.

Authors:  Sarah M Ronnebaum; Cam Patterson; Jonathan C Schisler
Journal:  Mol Endocrinol       Date:  2014-08-06

5.  Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines.

Authors:  Nifang Niu; Tongzheng Liu; Junmei Cairns; Reynold C Ly; Xianglin Tan; Min Deng; Brooke L Fridley; Krishna R Kalari; Ryan P Abo; Gregory Jenkins; Anthony Batzler; Erin E Carlson; Poulami Barman; Sebastian Moran; Holger Heyn; Manel Esteller; Liewei Wang
Journal:  Hum Mol Genet       Date:  2016-11-01       Impact factor: 6.150

Review 6.  Alterations in the E3 ligases Parkin and CHIP result in unique metabolic signaling defects and mitochondrial quality control issues.

Authors:  Britney N Lizama; Amy M Palubinsky; BethAnn McLaughlin
Journal:  Neurochem Int       Date:  2017-08-26       Impact factor: 3.921

Review 7.  The role of ubiquitin ligases in cardiac disease.

Authors:  Monte S Willis; Ariana Bevilacqua; Thomas Pulinilkunnil; Petra Kienesberger; Manasi Tannu; Cam Patterson
Journal:  J Mol Cell Cardiol       Date:  2013-11-19       Impact factor: 5.000

Review 8.  Cardiac ubiquitin ligases: Their role in cardiac metabolism, autophagy, cardioprotection and therapeutic potential.

Authors:  Traci L Parry; Monte S Willis
Journal:  Biochim Biophys Acta       Date:  2016-07-13

9.  CHIP Regulates Aquaporin-2 Quality Control and Body Water Homeostasis.

Authors:  Qi Wu; Hanne B Moeller; Donté A Stevens; Rebekah Sanchez-Hodge; Gabrielle Childers; Marleen L A Kortenoeven; Lei Cheng; Lena L Rosenbaek; Carrie Rubel; Cam Patterson; Trairak Pisitkun; Jonathan C Schisler; Robert A Fenton
Journal:  J Am Soc Nephrol       Date:  2017-12-14       Impact factor: 10.121

10.  Post-translationally modified muscle-specific ubiquitin ligases as circulating biomarkers in experimental cancer cachexia.

Authors:  Roberto Mota; Jessica E Rodríguez; Andrea Bonetto; Thomas M O'Connell; Scott A Asher; Traci L Parry; Pamela Lockyer; Christopher R McCudden; Marion E Couch; Monte S Willis
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.